A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...

Nerve cells have amazing strategies to save energy and still perform the most important of their tasks. Researchers from the ...

We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...

Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Nerve cells have amazing strategies to save energy and still perform the most important of their tasks. Researchers found that the neuronal energy conservation program determines the location and ...

The model calculations in the present study show that proteins are therefore preferably synthesized in the branched, tapering ...

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.